Review

Endocannabinoid Signaling in the Brain

Science  26 Apr 2002:
Vol. 296, Issue 5568, pp. 678-682
DOI: 10.1126/science.1063545

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

The primary psychoactive ingredient in cannabis, Δ9-tetrahydrocannabinol (Δ9-THC), affects the brain mainly by activating a specific receptor (CB1). CB1 is expressed at high levels in many brain regions, and several endogenous brain lipids have been identified as CB1 ligands. In contrast to classical neurotransmitters, endogenous cannabinoids can function as retrograde synaptic messengers: They are released from postsynaptic neurons and travel backward across synapses, activating CB1 on presynaptic axons and suppressing neurotransmitter release. Cannabinoids may affect memory, cognition, and pain perception by means of this cellular mechanism.

  • * To whom correspondence should be addressed. E-mail: nicoll{at}phy.ucsf.edu

View Full Text

Cited By...